These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38870506)

  • 1. Optimization of Hospital Drug Management Model under the Supervision of Internet Plus Medical Health.
    Zhang X; Xia F; Xiao C; Huang H; Chen T
    Altern Ther Health Med; 2024 Jun; ():. PubMed ID: 38870506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital.
    Luo H; Fan Q; Xiao S; Chen K
    BMC Health Serv Res; 2018 Jul; 18(1):537. PubMed ID: 29996830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton-pump inhibitor utilization associated with the change to nonpreferred formulary status for esomeprazole in the TRICARE formulary.
    Linton A; Bacon T; Peterson M
    J Manag Care Pharm; 2009; 15(1):42-54. PubMed ID: 19125549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of different proton pump inhibitors combined with bismuth quadruple regimens in Helicobacter pylori eradication.
    Kan LD; Chen J; Huang YT; Qiu Y; Yu XL; Fang HM; Chen Q; Li LC
    Clin Exp Med; 2020 Nov; 20(4):609-614. PubMed ID: 32651747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of nonformulary use of PPIs and excess drug cost in a Veterans Affairs population.
    Ajumobi AB; Vuong R; Ahaneku H
    J Manag Care Pharm; 2012; 18(1):63-7. PubMed ID: 22235956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study.
    Liu Y; Zhu X; Li R; Zhang J; Zhang F
    BMJ Open; 2020 Nov; 10(11):e040473. PubMed ID: 33243802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Proton Pump Inhibitors Prescribing Among Hospitalized Patients: A Cross-Sectional Study.
    Abukhalil AD; Ali O; Saad A; Falana H; Al-Shami N; Naseef HA; Rabba A
    Int J Gen Med; 2023; 16():141-150. PubMed ID: 36659914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities.
    Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T
    J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist and physician satisfaction and rates of switching to preferred medications associated with an instant prior authorization program for proton pump inhibitors in the North Carolina Medicaid program.
    Jacobson Vann JC; Christofferson S; Humble CG; Wegner SE; Feaganes JR; Trygstad TK
    J Manag Care Pharm; 2010 May; 16(4):250-63. PubMed ID: 20433216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of proton pump inhibitor management committee's multifaceted interventions on acid suppressant prescribing patterns in outpatient and emergency departments.
    Liu L; Yu Y; Fan Q; Wu Z; Li X; Luo H
    BMC Health Serv Res; 2022 Mar; 22(1):417. PubMed ID: 35351121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.
    Caro JJ; Salas M; Ward A
    Clin Ther; 2001 Jul; 23(7):998-1017. PubMed ID: 11519776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of proton pump inhibitors in children.
    Litalien C; Théorêt Y; Faure C
    Clin Pharmacokinet; 2005; 44(5):441-66. PubMed ID: 15871633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.
    Johnson JT; Neill KK; Davis DA
    J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of an intervention in an academic Internal Medicine Clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change.
    Ramser KL; Sprabery LR; Hamann GL; George CM; Will A
    J Manag Care Pharm; 2009 May; 15(4):344-50. PubMed ID: 19422274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?
    Clark DW; Strandell J
    Eur J Clin Pharmacol; 2006 Jun; 62(6):473-9. PubMed ID: 16758264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors: a study of GPs' prescribing.
    Jones MI; Greenfield SM; Jowett S; Bradley CP; Seal R
    Fam Pract; 2001 Jun; 18(3):333-8. PubMed ID: 11356744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a therapeutic maximum allowable cost (MAC) program on the cost and utilization of proton pump inhibitors in an employer-sponsored drug plan in Canada.
    Mabasa VH; Ma J
    J Manag Care Pharm; 2006 Jun; 12(5):371-6. PubMed ID: 16792443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overuse of PPIs in patients at admission, during treatment, and at discharge in a tertiary Spanish hospital.
    Ramirez E; Lei SH; Borobia AM; Piñana E; Fudio S; Muñoz R; Campos A; Carcas AJ; Frias J
    Curr Clin Pharmacol; 2010 Nov; 5(4):288-97. PubMed ID: 20925644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Awareness, attitude and behavior regarding proton pump inhibitor among medical staff in the Southwest of China.
    Luo H; Fan Q; Bian T; Li X; Chen K; Zhang Q; Wei Y; Xiao Y; Li Y
    BMC Health Serv Res; 2019 Nov; 19(1):880. PubMed ID: 31752835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of proton pump inhibitors anti-ulcer drugs use in the Araba district primary care area].
    Martínez Gorostiaga J; Echevarría Orella E; Calvo Hernáez B
    Rev Esp Salud Publica; 2018 Aug; 92():. PubMed ID: 30100604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.